Subscribe
Log In More

Log in via Institution
Log in via OpenAthens

Log in using your username and password
For personal accounts OR managers of institutional accounts

Username *

Password *

Forgot your log in details?Register a new account?
Forgot your user name or password?
Basket
Search More

Search for this keyword

Advanced search

Close More
Main menu

Latest content

Current issue

Archive

Authors

Podcasts

About
Subscribe
Log in More

Log in via Institution
Log in via OpenAthens

Log in using your username and password
For personal accounts OR managers of institutional accounts

Username *

Password *

Forgot your log in details?Register a new account?
Forgot your user name or password?
BMJ Journals More

Online First

July 22, 2019

Autoinflammatory disorders
Clinical characteristics and genetic analyses of 187 patients with undefined autoinflammatory diseases

Nienke M Ter Haar, Charlotte Eijkelboom, Luca Cantarini, Riccardo Papa, Paul A Brogan, Isabelle Kone-Paut, Consuelo Modesto, Michael Hofer, Nicolae Iagaru, Sárka Fingerhutová, Antonella Insalaco, Francesco Licciardi, Yosef Uziel, Marija Jelusic, Irina Nikishina, Susan Nielsen, Efimia Papadopoulou-Alataki, Alma Nunzia Olivieri, Rolando Cimaz, Gordana Susic, Valda Stanevica, Marielle van Gijn, Antonio Vitale, Nicolino Ruperto, Joost Frenkel, Marco Gattorno Eurofever registry and the Pediatric Rheumatology International Trial Organization (PRINTO)

doi: 10.1136/annrheumdis-2018-214472
Correspondence response
Treat to target in PsA should focus on clinical measures. Response to: ‘DAPSA versus cDAPSA: do we need use CRP?’ by Gonçalves et al
Free

Leonieke J J van Mens, Marleen G H van de Sande, Arno W R van Kuijk, Dominique Baeten, Laura C Coates

doi: 10.1136/annrheumdis-2019-215990
Correspondence
DAPSA versus cDAPSA: Do we need to use CRP?
Free

Rafaela Silva Guimarães Gonçalves, Lays Miranda de Almeida Martins, Henrique de Ataide Mariz, Andrea Tavares Dantas, Angela Luzia Branco Pinto Duarte

doi: 10.1136/annrheumdis-2019-215960
Review
The role of IL-17A in axial spondyloarthritis and psoriatic arthritis: recent advances and controversies

Dennis G McGonagle, Iain B McInnes, Bruce W Kirkham, Jonathan Sherlock, Robert Moots

doi: 10.1136/annrheumdis-2019-215356

July 20, 2019

Correspondence response
Response to: ‘On using machine learning algorithms to define clinically meaningful patient subgroups’ by Pinal-Fernandez and Mammen
Free

Olivier Benveniste, Yves Allenbach, Benjamin Granger

doi: 10.1136/annrheumdis-2019-216007

July 17, 2019

Vasculitis
Takayasu arteritis risk locus in IL6 represses the anti-inflammatory gene GPNMB through chromatin looping and recruiting MEF2–HDAC complex

Xiufang Kong, Amr H Sawalha

doi: 10.1136/annrheumdis-2019-215567
Crystal arthropathies
Genome-wide association study revealed novel loci which aggravate asymptomatic hyperuricaemia into gout

Yusuke Kawamura, Hirofumi Nakaoka, Akiyoshi Nakayama, Yukinori Okada, Ken Yamamoto, Toshihide Higashino, Masayuki Sakiyama, Toru Shimizu, Hiroshi Ooyama, Keiko Ooyama, Mitsuo Nagase, Yuji Hidaka, Yuko Shirahama, Kazuyoshi Hosomichi, Yuichiro Nishida, Ippei Shimoshikiryo, Asahi Hishida, Sakurako Katsuura-Kamano, Seiko Shimizu, Makoto Kawaguchi, Hirokazu Uemura, Rie Ibusuki, Megumi Hara, Mariko Naito, Mikiya Takao, Mayuko Nakajima, Satoko Iwasawa, Hiroshi Nakashima, Keizo Ohnaka, Takahiro Nakamura, Blanka Stiburkova, Tony R Merriman, Masahiro Nakatochi, Sahoko Ichihara, Mitsuhiro Yokota, Tappei Takada, Tatsuya Saitoh, Yoichiro Kamatani, Atsushi Takahashi, Kokichi Arisawa, Toshiro Takezaki, Keitaro Tanaka, Kenji Wakai, Michiaki Kubo, Tatsuo Hosoya, Kimiyoshi Ichida, Ituro Inoue, Nariyoshi Shinomiya, Hirotaka Matsuo

doi: 10.1136/annrheumdis-2019-215521

July 15, 2019

Correspondence response
Response to: ‘Semi-quantitative analysis of line blot assay for myositis-specific and myositis-associated antibodies: a better performance?’ by Cavazzana et al
Free

Johan Rönnelid, Fabricio Espinosa-Ortega, Ingrid E Lundberg

doi: 10.1136/annrheumdis-2019-215967
Correspondence
Semiquantitative analysis of line blot assay for myositis-specific and myositis-associated antibodies: a better performance?
Free

Ilaria Cavazzana, Micaela Fredi, Franco Franceschini

doi: 10.1136/annrheumdis-2019-215884

July 13, 2019

Recommendation
2018 Update of the EULAR recommendations for the management of large vessel vasculitis
Free

Bernhard Hellmich, Ana Agueda, Sara Monti, Frank Buttgereit, Hubert de Boysson, Elisabeth Brouwer, Rebecca Cassie, Maria C Cid, Bhaskar Dasgupta, Christian Dejaco, Gulen Hatemi, Nicole Hollinger, Alfred Mahr, Susan P Mollan, Chetan Mukhtyar, Cristina Ponte, Carlo Salvarani, Rajappa Sivakumar, Xinping Tian, Gunnar Tomasson, Carl Turesson, Wofgang Schmidt, Peter M Villiger, Richard Watts, Chris Young, Raashid Ahmed Luqmani

doi: 10.1136/annrheumdis-2019-215672
Correspondence
Response to: ‘Synovial cellular and molecular signatures stratify clinical response to csDMARD therapy and predict radiographic progression in early rheumatoid arthritis patients’ by Humby et al
Free

Maya H Buch, Andrew Melville, Dennis G McGonagle

doi: 10.1136/annrheumdis-2019-215881
Correspondence response
Response to ‘Synovial cellular and molecular signatures stratify clinical response to csDMARD therapy and predict radiographic progression in early rheumatoid arthritis patients’ by Humby et al
Free

Frances Humby, Myles Lewis, Michael J Townsend, Costantino Pitzalis

doi: 10.1136/annrheumdis-2019-215903
Inflammatory arthritis
Fexofenadine inhibits TNF signaling through targeting to cytosolic phospholipase A2 and is therapeutic against inflammatory arthritis

Ronghan Liu, Yuehong Chen, Wenyu Fu, Shuya Wang, Yazhou Cui, Xiangli Zhao, Zi-Ning Lei, Aubryanna Hettinghouse, Jody Liu, Chao Wang, Chen Zhang, Yufei Bi, Guozhi Xiao, Zhe-Sheng Chen, Chuan-ju Liu

doi: 10.1136/annrheumdis-2019-215543
Letter
Low specificity but high sensitivity of inflammatory back pain criteria in rheumatology settings in Europe: confirmation of findings from a German cohort study

Manouk de Hooge, Floris A van Gaalen, Thomas Renson, Ann-Sophie De Craemer, Marleen G van de Sande, Roberta Ramonda, Karen Minde Fagerli, Lennart T H Jacobsson, Désirée van der Heijde, Dirk Elewaut, Filip Van den Bosch

doi: 10.1136/annrheumdis-2019-215742

July 12, 2019

Letter
Patient and public involvement in biomedical research: training is not a substitute for relationship building

Anthony G Wilson, John Sherwin, Emma R Dorris

doi: 10.1136/annrheumdis-2019-215595
Rheumatoid arthritis
Potential involvement of OX40 in the regulation of autoantibody sialylation in arthritis

Izumi Kurata, Isao Matsumoto, Ayako Ohyama, Atsumu Osada, Hiroshi Ebe, Hoshimi Kawaguchi, Shunta Kaneko, Yuya Kondo, Hiroto Tsuboi, Azusa Tomioka, Hiroyuki Kaji, Takayuki Sumida

doi: 10.1136/annrheumdis-2019-215195
Recommendation
2018 update of the EULAR recommendations for the role of the nurse in the management of chronic inflammatory arthritis
Free

Bianca Bech, Jette Primdahl, Astrid van Tubergen, Marieke Voshaar, Heidi A Zangi, Lurdes Barbosa, Carina Boström, Boryana Boteva, Francesco Carubbi, Françoise Fayet, Ricardo J O Ferreira, Kirsten Hoeper, Agnes Kocher, Marja Leena Kukkurainen, Vivienne Lion, Patricia Minnock, Antonella Moretti, Mwidimi Ndosi, Milena Pavic Nikolic, Michael Schirmer, Hana Smucrova, Jenny de la Torre-Aboki, Jennifer Waite-Jones, Yvonne van Eijk-Hustings

doi: 10.1136/annrheumdis-2019-215458
Psoriatic arthritis
Incidence and time trends of joint surgery in patients with psoriatic arthritis: a register-based time series and cohort study from Denmark

Jørgen Guldberg-Møller, Rene Lindholm Cordtz, Lars Erik Kristensen, Lene Dreyer

doi: 10.1136/annrheumdis-2019-215313
Correspondence
Association between proton pump inhibitors therapy and fracture risk in patients with rheumatoid arthritis
Free

Shih-Wei Lai, Yu-Hung Kuo, Kuan-Fu Liao

doi: 10.1136/annrheumdis-2019-215982
Systemic Lupus erythematosus
Genetic variations in A20 DUB domain provide a genetic link to citrullination and neutrophil extracellular traps in systemic lupus erythematosus

Lina Odqvist, Zala Jevnikar, Rebecca Riise, Lisa Öberg, Magdalena Rhedin, Dag Leonard, Linda Yrlid, Sonya Jackson, Johan Mattsson, Sambit Nanda, Philip Cohen, Axel Knebel, Simon Arthur, Kristofer Thörn, Elisabet Svenungsson, Andreas Jönsen, Iva Gunnarsson, Karolina Tandre, Andrei Alexsson, Alf Kastbom, Solbritt Rantapää-Dahlqvist, Maija-Leena Eloranta, Ann-Christine Syvänen, Anders Bengtsson, Patrik Johansson, Johanna K Sandling, Christopher Sjöwall, Lars Rönnblom, Barry Collins, Outi Vaarala

doi: 10.1136/annrheumdis-2019-215434
Correspondence
Ultrasonographic salivary gland evaluation in systemic sclerosis: is sicca syndrome secondary to an authentic overlap syndrome or another specific fibrotic manifestation of the disease?
Free

Guillaume Coiffier, Sandrine Jousse-Joulin, Divi Cornec, Ronan Garlantézec, Aurore Bleuzen, Elisabeth Diot, Patrick Jego, Alice Ballerie, Alain Lescoat

doi: 10.1136/annrheumdis-2019-215972

July 11, 2019

Paediatric rheumatology
Development and initial validation of the MS score for diagnosis of macrophage activation syndrome in systemic juvenile idiopathic arthritis

Francesca Minoia, Francesca Bovis, Sergio Davì, AnnaCarin Horne, Michel Fischbach, Michael Frosch, Adam Huber, Marija Jelusic, Sujata Sawhney, Deborah K McCurdy, Clóvis A Silva, Donato Rigante, Erbil Unsal, Nicolino Ruperto, Alberto Martini, Randy Q Cron, Angelo Ravelli on behalf of the Pediatric Rheumatology International Trials Organization, the Childhood Arthritis & Rheumatology Research Alliance, the Pediatric Rheumatology Collaborative Study Group and the Histiocyte Society

doi: 10.1136/annrheumdis-2019-215211
Correspondence response
Response to: ‘Treatment of systemic lupus erythematosus: don’t forget hydroxychloroquine’ by Michaud et al
Free

Antonis Fanouriakis, George Bertsias, Dimitrios T Boumpas

doi: 10.1136/annrheumdis-2019-215817
Correspondence
On using machine learning algorithms to define clinically meaningful patient subgroups
Free

Rachel Knevel, Tom WJ Huizinga

doi: 10.1136/annrheumdis-2019-215959

July 08, 2019

Correspondence response
Mortality has improved in RA, but we must remain vigilant. Response to: ‘Early intensive treatment normalises excess mortality in ACPA-negative RA but not in ACPA-positive RA’ by Matthijssen et al
Free

Pomme B M Poppelaars, Lilian H D van Tuyl, Maarten Boers

doi: 10.1136/annrheumdis-2019-215863
Correspondence response
Response to: ‘Achieving lupus low disease activity and remission states under belimumab in refractory systemic lupuserythematosus: time and organ involvement matter’ by Sbeih et al
Free

Mandana Nikpour, Molla Huq, Shereen Oon

doi: 10.1136/annrheumdis-2019-215922
Correspondence
Achieving lupus low-disease activity and remission states under belimumab in refractory systemic lupus erythematosus: time and organ involvement matter
Free

Nabiha Sbeih, Alexis Mathian, Marc Pineton de Chambrun, Raphael Lhote, Noël Zahr, Micheline Pha, Fleur Cohen-Aubart, Julien Haroche, Miguel Hié, Sophie Jouffroy, Neila Benameur, Hervé Devilliers, Zahir Amoura

doi: 10.1136/annrheumdis-2019-215732
Epidemiology
Development and validation of risk stratification trees for incident slow gait speed in persons at high risk for knee osteoarthritis

Leena Sharma, Kent Kwoh, Jungwha (Julia) Lee, Jane Cauley, Rebecca Jackson, Marc Hochberg, Alison H Chang, Charles Eaton, Michael Nevitt, Jing Song, Orit Almagor, Joan S Chmiel

doi: 10.1136/annrheumdis-2019-215353
Correspondence response
Response to: ‘Association of proton pump inhibitors with fracture risk in patients with rheumatoid arthritis’ by Sugiyama
Free

Gulsen Ozen, Kaleb Michaud

doi: 10.1136/annrheumdis-2019-215775
Recommendation
EULAR points to consider for the use of big data in rheumatic and musculoskeletal diseases
Free

Laure Gossec, Joanna Kedra, Hervé Servy, Aridaman Pandit, Simon Stones, Francis Berenbaum, Axel Finckh, Xenofon Baraliakos, Tanja A Stamm, David Gomez-Cabrero, Christian Pristipino, Remy Choquet, Gerd R Burmester, Timothy R D J Radstake

doi: 10.1136/annrheumdis-2019-215694

July 05, 2019

Correspondence response
Response to: ‘Less antibiotics but no inferior effect for bacterial arthritis’ by Zhang et al
Free

Ilker Uçkay, Ergys Gjika

doi: 10.1136/annrheumdis-2019-215909
Correspondence
Is it currently reasonable to offer short, 14-day antibiotic therapies after a surgical synovectomy in native joint septic arthritis?
Free

Guillaume Coiffier, Marion Couderc, Raphaele Seror, Geraldine Bart, Christelle Darrieutort-Laffite, Benoit Le Goff

doi: 10.1136/annrheumdis-2019-215887
Correspondence response
Response to: ‘Is it currently reasonable to offer short 14-day antibiotic therapies after a surgical synovectomy in native joint septic arthritis?’ by Coiffier et al
Free

Ilker Uçkay, Amanda Gonzalez, Ergys Gjika

doi: 10.1136/annrheumdis-2019-215905
Correspondence
Less antibiotics but no inferior effect for bacterial arthritis
Free

Jian Tian, Chao Cheng, Fangjie Zhang

doi: 10.1136/annrheumdis-2019-215682

July 04, 2019

Correspondence response
Effects of maternal medication on long-term outcome in congenital heart block remain to be established. Response to: ‘Comorbidity and long-term outcome in patients with congenital heart block and their siblings exposed to Ro/SSA autoantibodies in utero’ by Satis et al
Free

Johannes Mofors, Sven-Erik Sonesson, Marie Wahren-Herlenius

doi: 10.1136/annrheumdis-2019-215677
Correspondence response
Response to: ‘Impact of Janus kinase inhibitors on the risk of cardiovascular events in patients with rheumatoid arthritis: systematic review and meta-analysis of randomised controlled trials’ by Lee and Song
Free

Wenhui Xie, Shiyu Xiao, Zhuoli Zhang

doi: 10.1136/annrheumdis-2019-215841
Correspondence response
Response to: ‘Can biomarkers differentiate psoriatic arthritis from osteoarthritis?’ by Tian et al
Free

Vinod Chandran, Richard J Cook, Dafna D Gladman

doi: 10.1136/annrheumdis-2019-215762
Correspondence response
Response to: ‘Neutrophil extracellular traps and low-density granulocytes are associated with the interferon signature in systemic lupus erythematosus, but not in antiphospholipid syndrome’ by van den Hoogen et al
Free

Mariana J Kaplan, Kerry A Casey

doi: 10.1136/annrheumdis-2019-215811

July 03, 2019

Correspondence response
Response to: ‘Concerns about the operational definition of remission in 2019 update of the EULAR recommendations for the management of systemic lupus erythematosus’ by Rua-Figueroa and Erausquin
Free

Antonis Fanouriakis, George Bertsias, Dimitrios T Boumpas

doi: 10.1136/annrheumdis-2019-215810
Correspondence
Bone health, an often forgotten comorbidity in systemic lupus erythematosus: a comment on the new recommendations
Free

Giovanni Orsolini, Irene Elizabeth Maria Bultink, Giovanni Adami, Angelo Fassio, Ombretta Viapiana, Alessandro Giollo, Davide Gatti, Maurizio Rossini

doi: 10.1136/annrheumdis-2019-215896
Correspondence response
Response to: ‘Comment on editorial ‘Pathogenic effector functions of ACPA: where do we stand’’ by Holmdahl
Free

René Toes, David S Pisetsky

doi: 10.1136/annrheumdis-2019-215870

June 27, 2019

Correspondence response
Response to: ‘Can IL-1 be used as a target for osteoarthritis?’ by Cheng et al
Free

Margreet Kloppenburg, Marc Levesque

doi: 10.1136/annrheumdis-2019-215612

June 25, 2019

Animal models
PPARγ preservation via promoter demethylation alleviates osteoarthritis in mice

Xiaobo Zhu, Fang Chen, Ke Lu, Ai Wei, Qing Jiang, Wangsen Cao

doi: 10.1136/annrheumdis-2018-214940

June 22, 2019

Correspondence
Early intensive treatment normalises excess mortality in ACPA-negative RA but not in ACPA-positive RA
Free

Xanthe ME Matthijssen, Tom WJ Huizinga, Ellis Niemantsverdriet, Annette HM van der Helm-van Mil

doi: 10.1136/annrheumdis-2019-215843

June 21, 2019

Systemic sclerosis
Predictors of disease worsening defined by progression of organ damage in diffuse systemic sclerosis: a European Scleroderma Trials and Research (EUSTAR) analysis

Mike Becker, Nicole Graf, Rafael Sauter, Yannick Allanore, John Curram, Christopher P Denton, Dinesh Khanna, Marco Matucci-Cerinic, Janethe de Oliveira Pena, Janet E Pope, Oliver Distler EUSTAR Collaborators

doi: 10.1136/annrheumdis-2019-215145
Correspondence
On using machine learning algorithms to define clinically meaningful patient subgroups
Free

Iago Pinal-Fernandez, Andrew Lee Mammen

doi: 10.1136/annrheumdis-2019-215852
Correspondence
Comment on editorial ‘Pathogenic effector functions of ACPA: where do we stand?’
Free

Rikard Holmdahl

doi: 10.1136/annrheumdis-2019-215857

June 19, 2019

Correspondence response
Response to: ‘Mycophenolate mofetil: a step forward in the induction treatment of ANCA-associated vasculitis? Comment on the article by Jones et al’ by Vandergheynst et al
Free

Rachel B Jones, Thomas F Hiemstra, Michael Walsh, David Jayne, Lorraine Harper

doi: 10.1136/annrheumdis-2019-215658
Systemic lupus erythematosus
Association of Epstein-Barr virus serological reactivation with transitioning to systemic lupus erythematosus in at-risk individuals

Neelakshi R Jog, Kendra A Young, Melissa E Munroe, Michael T Harmon, Joel M Guthridge, Jennifer A Kelly, Diane L Kamen, Gary S Gilkeson, Michael H Weisman, David R Karp, Patrick M Gaffney, John B Harley, Daniel J Wallace, Jill M Norris, Judith A James

doi: 10.1136/annrheumdis-2019-215361
Rheumatoid arthritis
Non-response to rituximab therapy in rheumatoid arthritis is associated with incomplete disruption of the B cell receptor repertoire

Sabrina Pollastro, Paul L Klarenbeek, Marieke E Doorenspleet, Barbera D C van Schaik, Rebecca E E Esveldt, Rogier M Thurlings, Maria J H Boumans, Danielle M Gerlag, Paul P Tak, Koen Vos, Frank Baas, Antoine H C van Kampen, Niek de Vries

doi: 10.1136/annrheumdis-2018-214898

Log in using your username and password

Main menu

Log in using your username and password

You are here

Online First

July 22, 2019

July 20, 2019

July 17, 2019

July 15, 2019

July 13, 2019

July 12, 2019

July 11, 2019

July 08, 2019

July 05, 2019

July 04, 2019

July 03, 2019

June 27, 2019

June 25, 2019

June 22, 2019

June 21, 2019

June 19, 2019

Pages